Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SHREE ASHTAVINAYAK SALES CORPORATION | 1 | ₹354 |
| 2 | Schedule 2 | SUKUN PHARMA | 1 | ₹1,710 |
| 3 | Schedule 3 | SUKUN PHARMA | 1 | ₹780 |
| 4 | Schedule 4 | SUPREME INTERNATIONAL PHARMACEUTICALS | 1 | ₹2,610 |
| 5 | Schedule 5 | SUKUN PHARMA | 1 | ₹87 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Jan 2024, 9:00 amClosed
Drugs and Pharmaceuticals
5813448
GEM/2023/B/4408148
Two Packet Bid
Fenofibrate 200 mg Tab,Telmisartan 40 mg Tab,Telmisartan 40 mg plus Hydrochlorthiazide 12 point 5 m
21 days
Rajasthan; Barmer
Item wise evaluation
BOQ
5 documents required · 5 mandatory
10%
Exempted
8 Jan 2024
28 Dec 2023
8 Jan 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Fenofibrate 200 mg Tab | 300 | No | Barmer | 21 |
| 2 | Telmisartan 40 mg Tab | 3,000 | No | Barmer | 21 |
| 3 | Telmisartan 40 mg plus Hydrochlorthiazide 12 point 5 mg Tab | 1,200 | No | Barmer | 21 |
| 4 | Tab Fexofenadine 180 mg | 1,800 | No | Barmer | 21 |
| 5 | Tab Clinidipine 10 mg | 300 | No | Barmer | 21 |
| 6 | Asprin 75 mg Tab | 2,400 | No | Barmer | 21 |
| 7 | Aspirin 150 mg Tab | 1,500 | No | Barmer | 21 |
| 8 | Oxcarbazepine 300 mg Tab | 600 | No | Barmer | 21 |
| 9 | Phenytoin Sodium 100 mg Tab | 600 | No | Barmer | 21 |
| 10 | Tab Nicorandil 10 mg | 300 | No | Barmer | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5813448.pdf
GEM_BID
terms___conditions__2023-12-28-21-43-22_1c192c8df264052df0759b2a9569c3d8.pdf
BOQ
boq_item_sample_file_2023-12-28-21-43-22_2672cadc130668b5f4762d9e414360c9.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .